Nexaph peptides represent a groundbreaking therapeutic strategy targeting disease progression. These specially designed molecules leverage the unique properties of short peptide sequences to modulate cellular activities involved in swelling, fibrosis, and neoplasm growth. Studies suggest their potential for treating a spectrum of chronic diseases,